Carl B. Feldbaum

Director, CONNETICS CORP.

Companies

ExelixisBoard member Feb 9, 2007 to Feb 10, 2023¹
Cardiff Oncology, Inc.Board member Jan 6, 2015 to Mar 19, 2015²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Exelixis EXEL18,701 shares³$1.2M at $62.59Feb 9, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Feb 9, 2023Sold 40,000 shares at $17.78 of Exelixis³
Feb 9, 2023Exercised options 40,000 shares at $6.30 of Exelixis³
May 26, 2022Granted 10,180 shares of Exelixis⁴
Feb 22, 2022Sold 20,000 shares at $19.49 of Exelixis⁵
Feb 22, 2022Exercised options 20,000 shares at $3.13 of Exelixis⁵
Nov 19, 2021Sold 20,000 shares at $17.62 of Exelixis⁶
Nov 19, 2021Exercised options 20,000 shares at $3.13 of Exelixis⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARExelixis, Board member
2
SEC EDGARCardiff Oncology, Inc., Board member
3
SEC EDGARExelixis shares after the filing of Feb 9, 2023
4
SEC EDGARForm 4 filed May 27, 2022
5
SEC EDGARForm 4 filed Feb 24, 2022
6
SEC EDGARForm 4 filed Nov 23, 2021